SEARCH

SEARCH BY CITATION

References

  • Altschul, S.F., Madden, T.L., Schaffer, A.A., Zhang, J., Zhang, Z., Miller, W., and Lipman, D.J. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 33893402.
  • Arduino, R.C., Murray, B.E., and Rakita, R.M. (1994) Roles of antibodies and complement in phagocytic killing of enterococci. Infect Immun 62: 987993.
  • Aso, Y., Okuda, K., Nagao, J., Kanemasa, Y., Thi Bich Phuong, N., Koga, H., et al. (2005) A novel type of immunity protein, NukH, for the lantibiotic nukacin ISK-1 produced by Staphylococcus warneri ISK-1. Biosci Biotechnol Biochem 69: 14031410.
  • Breukink, E., and De Kruijff, B. (2006) Lipid II as a target for antibiotics. Nat Rev Drug Discov 5: 321323.
  • Brumfitt, W., Salton, M.R., and Hamilton-Miller, J.M. (2002) Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. J Antimicrob Chemother 50: 731734.
  • Chatterjee, C., Paul, M., Xie, L., and Van Der Donk, W.A. (2005) Biosynthesis and mode of action of lantibiotics. Chem Rev 105: 633684.
  • Cotter, P.D., Hill, C., and Ross, R.P. (2003) A food-grade approach for functional analysis and modification of native plasmids in Lactococcus lactis. Appl Environ Microbiol 69: 702706.
  • Cotter, P.D., Hill, C., and Ross, R.P. (2005) Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 3: 777788.
  • Cotter, P.D., Deegan, L.H., Lawton, E.M., Draper, L.A., O'Connor, P.M., Hill, C., and Ross, R.P. (2006a) Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design. Mol Microbiol 62: 735747.
  • Cotter, P.D., Draper, L.A., Lawton, E.M., McAuliffe, O., Hill, C., and Ross, R.P. (2006b) Overproduction of wild-type and bioengineered derivatives of the lantibiotic lacticin 3147. Appl Environ Microbiol 72: 44924496.
  • Draper, L.A., Ross, R.P., Hill, C., and Cotter, P.D. (2008) Lantibiotic immunity. Curr Protein Pept Sci 9: 3949.
  • Galvin, M., Hill, C., and Ross, R.P. (1999) Lacticin 3147 displays activity in buffer against gram-positive bacterial pathogens which appear insensitive in standard plate assays. Lett Appl Microbiol 28: 355358.
  • Gasson, M.J. (1983) Plasmid complements of Streptococcus lactis NCDO 712 and other lactic streptococci after protoplast-induced curing. J Bacteriol 154: 19.
  • Guder, A., Wiedemann, I., and Sahl, H.G. (2000) Posttranslationally modified bacteriocins – the lantibiotics. Biopolymers 55: 6273.
  • Guinane, C.M., Cotter, P.D., Hill, C., and Ross, R.P. (2006) Spontaneous resistance in Lactococcus lactis IL1403 to the lantibiotic lacticin 3147. FEMS Microbiol Lett 260: 7783.
  • Heidrich, C., Pag, U., Josten, M., Metzger, J., Jack, R.W., Bierbaum, G., et al. (1998) Isolation, characterization, and heterologous expression of the novel lantibiotic epicidin 280 and analysis of its biosynthetic gene cluster. Appl Environ Microbiol 64: 31403146.
  • Hoffmann, A., Schneider, T., Pag, U., and Sahl, H.G. (2004) Localization and functional analysis of PepI, the immunity peptide of Pep5-producing Staphylococcus epidermidis strain 5. Appl Environ Microbiol 70: 32633271.
  • Holo, H., and Nes, I.F. (1995) Transformation of Lactococcus by electroporation. Methods Mol Biol 47: 195199.
  • Ito, K., Oleschuk, C.J., Westlake, C., Vasa, M.Z., Deeley, R.G., and Cole, S.P. (2001) Mutation of Trp1254 in the multispecific organic anion transporter, multidrug resistance protein 2 (MRP2) (ABCC2), alters substrate specificity and results in loss of methotrexate transport activity. J Biol Chem 276: 3810838114.
  • Kleerebezem, M., Boekhorst, J., Van Kranenburg, R., Molenaar, D., Kuipers, O.P., Leer, R., et al. (2003) Complete genome sequence of Lactobacillus plantarum WCFS1. Proc Natl Acad Sci USA 100: 19901995.
  • Koning, S., Van Belkum, A., Snijders, S., Van Leeuwen, W., Verbrugh, H., Nouwen, J., et al. (2003) Severity of nonbullous Staphylococcus aureus impetigo in children is associated with strains harboring genetic markers for exfoliative toxin B, Panton-Valentine leukocidin, and the multidrug resistance plasmid pSK41. J Clin Microbiol 41: 30173021.
  • Kramer, N.E., Van Hijum, S.A., Knol, J., Kok, J., and Kuipers, O.P. (2006) Transcriptome analysis reveals mechanisms by which Lactococcus lactis acquires nisin resistance. Antimicrob Agents Chemother 50: 17531761.
  • Kruszewska, D., Sahl, H.G., Bierbaum, G., Pag, U., Hynes, S.O., and Ljungh, A. (2004) Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model. J Antimicrob Chemother 54: 648653.
  • Kuipers, O.P., Rollema, H.S., De Vos, W.M., and Siezen, R.J. (1993) Biosynthesis and secretion of a precursor of nisin Z by Lactococcus lactis, directed by the leader peptide of the homologous lantibiotic subtilin from Bacillus subtilis. FEBS Lett 330: 2327.
  • Kuipers, O.P., Beerthuyzen, M.M., De Ruyter, P.G., Luesink, E.J., and De Vos, W.M. (1995) Autoregulation of nisin biosynthesis in Lactococcus lactis by signal transduction. J Biol Chem 270: 2729927304.
  • Law, J., Buist, G., Haandrikman, A., Kok, J., Venema, G., and Leenhouts, K. (1995) A system to generate chromosomal mutations in Lactococcus lactis which allows fast analysis of targeted genes. J Bacteriol 177: 70117018.
  • Lawton, E.M., Ross, R.P., Hill, C., and Cotter, P.D. (2007) Two peptide lantibiotics: a medical perspective. Mini Rev Med Chem 7: 12361247.
  • Leenhouts, K.J., Buist, G., Bolhuis, A., Ten Berge, A., Kiel, J., Mierau, I., et al. (1996) A gene system for generating unlabelled gene replacements in bacterial chromosomes. Mol Gen Genet 253: 217224.
  • Linnan, M.J., Mascola, L., Lou, X.D., Goulet, V., May, S., Salminen, C., et al. (1988) Epidemic listeriosis associated with Mexican-style cheese. N Engl J Med 319: 823828.
  • McAuliffe, O., Hill, C., and Ross, R.P. (2000) Identification and overexpression of ltnl, a novel gene which confers immunity to the two-component lantibiotic lacticin 3147. Microbiology 146: 129138.
  • McAuliffe, O., Ross, R.P., and Hill, C. (2001a) Lantibiotics: structure, biosynthesis and mode of action. FEMS Microbiolrev 25: 285308.
  • McAuliffe, O., O'Keeffe, T., Hill, C., and Ross, R.P. (2001b) Regulation of immunity to the two-component lantibiotic, lacticin 3147, by the transcriptional repressor LtnR. Mol Microbiol 39: 982993.
  • McGrath, S., Fitzgerald, G.F., and Van Sinderen, D. (2001) Improvement and optimization of two engineered phage resistance mechanisms in Lactococcus lactis. Appl Environ Microbiol 67: 608616.
  • Maguin, E., Duwat, P., and Gruss, A. (1992) New thermosensitive plasmid for Gram-positive bacteria. J Bacteriol 174: 56335638.
  • Mealey, R.H., Lee, J.H., Leib, S.R., Littke, M.H., and McGuire, T.C. (2006) A Single amino acid difference within the {alpha}-2 domain of two naturally occurring equine MHC class I molecules alters the recognition of gag and rev epitopes by equine infectious anemia virus-specific CTL. J Immunol 177: 73777390.
  • Morgan, S.M., O'Connor, P.M., Cotter, P.D., Ross, R.P., and Hill, C. (2005) Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations. Antimicrob Agents Chemother 49: 26062611.
  • Mulligan, M.E., Murray-Leisure, K.A., Ribner, B.S., Standiford, H.C., John, J.F., Korvick, J.A., Kauffman, C.A., and Yu, V.L. (1993) Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 94: 313328.
  • Murray, B.E. (1998) Diversity among multidrug-resistant enterococci. Emerg Infect Dis 4: 3747.
  • Navaratna, M.A., Sahl, H.G., and Tagg, J.R. (1999) Identification of genes encoding two-component lantibiotic production in Staphylococcus aureus C55 and other phage group II S. aureus strains and demonstration of an association with the exfoliative toxin B gene. Infect Immun 67: 42684271.
  • Novick, R.P., and Morse, S.I. (1967) In vivo transmission of drug resistance factors between strains of Staphylococcus aureus. J Exp Med 125: 4559.
  • O'Connor, E.B., Cotter, P.D., O'Connor, P., O'Sullivan, O., Tagg, J.R., Ross, R.P., and Hill, C. (2007) Relatedness between the two-component lantibiotics lacticin 3147 and staphylococcin C55 based on structure, genetics and biological activity. BMC Microbiol 7: 24.
  • Okuda, K., Aso, Y., Nakayama, J., and Sonomoto, K. (2008) Cooperative transport between NukFEG and NukH in immunity against the lantibiotic nukacin ISK-1 produced by Staphylococcus warneri ISK-1. J Bacteriol 190: 356362.
  • Pag, U., and Sahl, H.G. (2002) Multiple activities in lantibiotics – models for the design of novel antibiotics? Curr Pharm Des 8: 815833.
  • Park, S.F., and Stewart, G.S. (1990) High-efficiency transformation of Listeria monocytogenes by electroporation of penicillin-treated cells. Gene 94: 129132.
  • Peschel, A., Schnell, N., Hille, M., Entian, K.D., and Gotz, F. (1997) Secretion of the lantibiotics epidermin and gallidermin: sequence analysis of the genes gdmT and gdmH, their influence on epidermin production and their regulation by EpiQ. Mol Gen Genet 254: 312318.
  • Phelps, H.A., and Neely, M.N. (2007) SalY of the Streptococcus pyogenes lantibiotic locus is required for full virulence and intracellular survival in macrophages. Infect Immun 75: 45414551.
  • Rogolsky, M., Beall, B.W., and Wiley, B.B. (1986) Transfer of the plasmid for exfoliative toxin B synthesis in mixed cultures on nitrocellulose membranes. Infect Immun 54: 265268.
  • Ryan, M.P., Rea, M.C., Hill, C., and Ross, R.P. (1996) An application in cheddar cheese manufacture for a strain of Lactococcus lactis producing a novel broad-spectrum bacteriocin, lacticin 3147. Appl Environ Microbiol 62: 612619.
  • Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989) Molecular cloning: a laboratory manual. 2nd edn. Cold Springs Habor, NY: Cold Springs Harbor Laboratory.
  • Stein, T., Heinzmann, S., Dusterhus, S., Borchert, S., and Entian, K.D. (2005) Expression and functional analysis of the subtilin immunity genes spaIFEG in the subtilin-sensitive host Bacillus subtilis MO1099. J Bacteriol 187: 822828.
  • Takala, T.M., and Saris, P.E. (2006) C terminus of NisI provides specificity to nisin. Microbiology 152: 35433549.
  • Twomey, D., Ross, R.P., Ryan, M., Meaney, B., and Hill, C. (2002) Lantibiotics produced by lactic acid bacteria: structure, function and applications. Antonie Van Leeuwenhoek 82: 165185.
  • Veith, B., Herzberg, C., Steckel, S., Feesche, J., Maurer, K.H., Ehrenreich, P., et al. (2004) The complete genome sequence of Bacillus licheniformis DSM13, an organism with great industrial potential. J Mol Microbiol Biotechnol 7: 204211.
  • Wiedemann, I., Breukink, E., Van Kraaij, C., Kuipers, O.P., Bierbaum, G., De Kruijff, B., and Sahl, H.G. (2001) Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J Biol Chem 276: 17721779.
  • Wiedemann, I., Bottiger, T., Bonelli, R.R., Wiese, A., Hagge, S.O., Gutsmann, T., et al. (2006) The mode of action of the lantibiotic lacticin 3147 – a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II. Mol Microbiol 61: 285296.
  • Yamaguchi, T., Hayashi, T., Takami, H., Ohnishi, M., Murata, T., Nakayama, K., et al. (2001) Complete nucleotide sequence of a Staphylococcus aureus exfoliative toxin B plasmid and identification of a novel ADP-ribosyltransferase, EDIN-C. Infect Immun 69: 77607771.